Schedule M
Revised Schedule M: Complete Guide for Small Pharma Manufacturers (2025)
Everything you need to know about the revised Schedule M GMP guidelines — from key changes to compliance timelines for MSME pharma units.
Read Article →Consflick
Consflick delivers structured GMP, WHO pre-qualification, and Schedule M compliance consulting exclusively for Indian pharma MSMEs — at pricing built for ₹2–80 Cr manufacturers.
Clients Served
Audit Pass Rate
Pharma Clusters
Weeks to Compliance
India has 6.3 crore MSMEs. Less than 4% access formal consulting — not because they don't need it, but because McKinsey and Deloitte weren't built for them.
Consflick was. We are a boutique consulting firm exclusively serving pharmaceutical manufacturers with revenues between ₹2–80 Crore — the forgotten middle ground where compliance pressure is highest and support is almost nonexistent.
Structured, transparent fees. No ₹10L minimums. No surprises.
We own the result — compliance achieved — not just the paperwork filed.
On-site teams in Vapi, Baddi, Hyderabad — not remote-only advisors.
Proactive CDSCO, WHO, Schedule M alerts before they become fines.
Phase 1 services — high-urgency, high-repeatability, priced for ₹2–80 Cr manufacturers.
On-site audit, comprehensive gap report, and SOP framework for CDSCO compliance.
End-to-end documentation, mock audit, training, and WHO Pre-qualification preparation — first attempt success.
Full set of 50–100 customized Standard Operating Procedures for your manufacturing unit.
ISO 9001 / GMP Quality Management System complete design and implementation for your unit.
Drug license applications, Form 44, amendments, and renewal management — zero-delay processing.
On-site GMP training workshops for your QA and production teams — practical and compliance-oriented.
Ongoing regulatory advisory, document management, CDSCO alerts, and compliance monitoring — your QA department on call.
On-ground presence in India's top pharmaceutical manufacturing hubs.
30-minute call with our consultant to understand your unit, compliance status, and most urgent risks.
Our specialist visits your facility, evaluates against Schedule M / WHO standards, and documents every gap.
Detailed action plan with priorities, timelines, and fixed-fee pricing. You know exactly what it will cost.
We build your SOPs, train your team, upgrade your QMS, and file your documentation — you run your business.
Mock audit, final documentation review, and live regulatory audit support. 98% first-attempt success rate.
"Consflick helped us achieve full Schedule M compliance in just 6 weeks. Their audit was thorough, their SOPs were world-class. We renewed our license without a single CDSCO query."
"The WHO-GMP Readiness Program by Consflick was a game-changer. We cleared the WHO pre-qualification audit in the first attempt — something we had struggled with for 2 years."
"Very professional team. They created our entire SOP library from scratch and trained our staff. Highly recommend for any small pharma company wanting compliance at an affordable price."
Everything you need to know about the revised Schedule M GMP guidelines — from key changes to compliance timelines for MSME pharma units.
Read Article →A step-by-step roadmap for small pharmaceutical manufacturers in India to prepare for WHO Pre-qualification.
Read →Form 44 rejections cost pharma MSMEs months of delay. Here are the top 7 mistakes and exactly how to fix them.
Read →Tell us about your unit and we'll schedule a discovery call within 24 hours. No obligation, no hard sell — just an honest assessment of where you stand.